CAS RN: 1150701-66-8

1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide

Product Availability

Choose a grade to view its available package options.

6 package records4 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260209 5mg / 10mg Confirm by inquiry Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260422 100mg Out of stock Inquiry
Batchno.20260319 10mg In stock Shanghai Inquiry
Batchno.20250115 250mg Out of stock Inquiry
Batchno.20250318 25mg In stock Shanghai Inquiry
Batchno.20251207 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1150701-66-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1150701-66-8 / 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide

SCD inhibitor 1 | GSK1940029 | 1-[(3,4-dichlorophenyl)methyl]-n-[4-(hydroxymethyl)phenyl]-5-methyl-1h-1,2,3-triazole-4-carboxamide

Standard CAS: 1150701-66-8 Multi CAS: No

Basic Information

CAS
1150701-66-8
Multi CAS
No
Molecular Formula
C18H16Cl2N4O2
Molecular Weight
391.200000
Exact Mass
390.065031
SMILES
CC1=C(N=NN1CC2=CC(=C(C=C2)Cl)Cl)C(=O)NC3=CC=C(C=C3)CO
InChI
InChI=1S/C18H16Cl2N4O2/c1-11-17(18(26)21-14-5-2-12(10-25)3-6-14)22-23-24(11)9-13-4-7-15(19)16(20)8-13/h2-8,25H,9-10H2,1H3,(H,21,26)
InChIKey
QQRGSFYTPBYCFD-UHFFFAOYSA-N
Synonyms
SCD inhibitor 1 GSK1940029 1-[(3,4-dichlorophenyl)methyl]-n-[4-(hydroxymethyl)phenyl]-5-methyl-1h-1,2,3-triazole-4-carboxamide 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide D inhibitor GSK1940029

Computed Properties

Structural Parameters

Heavy atom count
26
Aromatic heavy atom count
17
Fraction Csp3
0.17
Rotatable bonds
5
H-bond acceptors
5
H-bond donors
2
Molar refractivity
100.64
TPSA
80.04

LogP / Solubility

WLOGP
3.69
MLOGP
3.27
XLogP3
3.2
Consensus LogP
3.39
Log S (ESOL)
-4.74
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.43
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.86
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.49

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us